Invivyd, Inc.

NASDAQ:IVVD

Biotechnology

Healthcare
$0.47 +4.16%

+$0.04 today

Market cap
$138.68M
Beta
0.63
P/E (TTM)
-3.9
EPS (TTM)
-$0.25
52W Low $0.48High $3.07

Volume 6.71M

Average 3.62M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$58.13M

FY 2025 · Annual

Investing Cash Flow

-$155,000.00

FY 2025 · Annual

Financing Cash Flow

$215.63M

FY 2025 · Annual

+448.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(226.79M)(241.32M)(198.64M)(169.93M)(52.49M)
Depreciation & Amortization1K462K2.03M3.11M2.11M
Deferred Income Tax00000
Stock-Based Compensation17.76M21.65M18.69M19.79M11.64M
Change in Working Capital22.79M(16.13M)5.89M(23.47M)(19.69M)
Accounts Receivables000(10.91M)(3.34M)
Inventory000(24.89M)(373K)
Accounts Payables(2.37M)(4.3M)6.47M2.42M3.21M
Other Working Capital25.16M(11.83M)(583K)9.91M(19.2M)
Other Non-Cash Items1.5M15.35M(1.12M)19.79M298K
Operating Cash Flow(184.74M)(219.99M)(173.16M)(170.49M)(58.14M)
Capital Expenditures(84K)(1.71M)(615K)(140K)(155K)
Acquisitions (Net)00000
Purchases of Investments(188.63M)(297.96M)(91.2M)00
Sales of Investments138M69M372.5M00
Other Investing Activities00000
Investing Cash Flow(50.71M)(230.67M)280.68M(140K)(155K)
Debt Repayment00000
Common Stock Issued330.91M510K1.2M39.29M215.63M
Common Stock Repurchased0(4K)(1K)00
Dividends Paid00000
Other Financing Activities(3.39M)510K1.05M46K0
Financing Cash Flow662.68M506K1.05M39.33M215.63M
Effect of Forex Changes0008K0
Net Change in Cash427.24M(450.15M)108.57M(131.29M)157.34M
Free Cash Flow(184.82M)(221.69M)(173.78M)(170.63M)(58.29M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$52.5M
+ D&A$2.1M
+ Stock-Based Comp$11.6M
+ Deferred Tax$0
- Working Capital-$19.7M
+ Other Non-Cash$298.0K
= Operating Cash Flow-$58.1M
- Capex-$155.0K
= Free Cash Flow-$58.3M

Analysis

FY2025 free cash flow is -$58.3M. FCF conversion is 111.1% of net income. Operating cash flow was -$58.1M, with capex of -$155.0K. The largest bridge item is Working Capital at -$19.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 29, 2026
3Initial statement of beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipSep 2, 2026
4Statement of changes in beneficial ownershipSep 1, 2026
8-KCurrent reportSep 1, 2026

Does IVVD generate free cash flow?

Invivyd, Inc. (IVVD) generated -$58.29M of free cash flow in fiscal 2025.

How much operating cash flow does IVVD produce?

Operating cash flow was -$58.13M, before capital expenditures of $155,000.00.